Exploring Empowering Trial Design And Optimal Dosing With Simcyp Simulator V24
Exploring Empowering Trial Design And Optimal Dosing With Simcyp Simulator V24 reveals several interesting facts.
- Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary ...
- Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary ...
- This e-learning video takes you through the capabilities user interface of the
- This introductory video for the Simcyp Absorption I Focused Workshop provides a general tour of the
- Physiologically-based pharmacokinetic (PBPK) modeling and
In-Depth Information on Empowering Trial Design And Optimal Dosing With Simcyp Simulator V24
Topics Covered: - New Certara's In this video, Ellen Leinfuss, Senior Vice President, Certara, talks with Dr. Udoamaka Ezuruike, Research Scientist II, Certara, who ... Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary ...
Tailored for discovery and translational scientists,
Stay tuned for more updates related to Empowering Trial Design And Optimal Dosing With Simcyp Simulator V24.